96. Crohn disease Clinical trials / Disease details

Clinical trials : 2,400 / Drugs : 1,391 - (DrugBank : 267) / Drug target genes : 170 - Drug target pathways : 215

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00427804 (ClinicalTrials.gov)	January 2007	25/1/2007	Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption	Tumor Necrosis Factor-a Induces Vitamin D Resistance in Small Intestinal Calcium Absorption	Rheumatoid Arthritis;Crohn's Disease	Drug: calcitriol	Atlanta VA Medical Center	Emory University	Completed	18 Years	50 Years	Male	9	N/A	United States
2	NCT00287170 (ClinicalTrials.gov)	July 2006	2/2/2006	Efficacy Study of Targeted, Local Delivery of Drugs to Treat Crohn's Disease	Pilot, Open-Label, Randomized, Parallel Group Study to Evaluate Clinical/ and Immunological Efficacy/Safety of Locally Delivered 6-MP or Calcitriol vs Purinethol in Non-Steroid Dependent Patients With Active CD	Crohn's Disease	Drug: Delayed Release 6MP or Calcitriol vs. Purinethol	Teva GTC	NULL	Completed	18 Years	75 Years	Both	15	Phase 1/Phase 2	Israel